An Innovative Image Guided Radiofrequency Ablation System to treat Atrial Fibrillation

Project Information

ABLAVIEW

Grant agreement ID: 850330

DOI 10.3030/850330

Project closed

EC signature date 12 April 2019

Start date 1 May 2019

End date 30 April 2023

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 3 524 880,00

EU contribution € 2 467 416,00

Coordinated by

MEDLUMICS SL
Spain

Deliverables

Other (1)

Website update and dissemination activities

Publications

Conference proceedings (3)

Photonically Guided Direct Lesion Assessment

Author(s): Atul Verma, David Herranz, Christophe Bailleul, James L. Greene , Matthieu Duperron, Juan Sancho.
Published in: AF SYMPOSIUM 2021 - XXI. EARLY STAGE and EMERGING NEW TECHNOLOGIES and DRUGS in CARDIAC EP III, Issue January 31st, 2021, 2021
Publisher: AF SYMPOSIUM 2021

Predicting Durability of PFA Lesions Using an Optically Guided Catheter (MedLumics)

Author(s): Atul Verma
Published in: AF SYMPOSIUM 2023, Issue January 21st, 2023, 2023
Publisher: AF SYMPOSIUM 2023

Direct Lesion Assessment using Photonics during Catheter Ablation for the treatment of AF

Author(s): Sabine Ernst, David Herranz, Christophe Bailleul, James L. Greene , Matthieu Duperron, Juan Sancho.
Published in: Atrial Signals 2021, Issue September 23rd, 2021, 2021
Publisher: Atrial-Signals 2021 - KIT